Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 12:40 PM
Ignite Modification Date:
2025-12-24 @ 12:40 PM
NCT ID:
NCT00638261
Brief Title:
Primary UVB-311nm and Adalimumab in Psoriasis Patients
Official Title:
Adalimumab in Primary Combination With UVB-311nm Half-side Phototherapy in Patients With Psoriasis
Study:
NCT00638261
Protocol Section:
NCT00638261